Search
for
Sort by
Research 601–630 of 1000+
- Alopecia areata: medical treatments
- Battling a receding tide: Treatment for androgenic alopecia
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Drug-induced Telogen Effluvium in a Pediatric Patient due to Error of Transcription.
- Alopecia areata after mogamulizumab treatment
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
- N-acetylcysteine in the treatment of trichotillomania
- Diphencyprone Induced Vitiligo: A Case Report
- Isolated Linear Discoid Lupus Erythematosus of Scalp Following Lines of Blaschko
- Metabolic and Vascular Inflammation in Alopecia Areata: Linking Uric Acid, Lipid Imbalance and ICAM ‐1 Upregulation
- Alopecia universalis following human papillomavirus vaccine administration: a case report
- Dupilumab treatment for atopic dermatitis leading to unexpected treatment for alopecia universalis
- SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Cancer-Related Alopecia Risk and Treatment
- Management of Alopecia and Onychomycosis in a Lupus Patient
- Frontal Fibrosing Alopecia in Men: A Review of the Literature
- Syphilitic alopecia: uncommon trichoscopic findings
- Successful treatment of alopecia universalis with abrocitinib: a case report
- Alopecia universalis during treatment with leflunomide and adalimumab - Case report
- Allergic contact dermatitis of the scalp: a review of an underdiagnosed entity
- Use of diphenylcyclopropenone for alopecia areata treatment during pregnancy
- Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia